BETHESDA, Md., Feb. 1, 2019 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) announced plans to release the results of its 2019 Technology Transfers Survey during the 2019 PDA Annual Meeting at the Marriott Marquis San Diego, Calif., March 11 – 13. The survey results will be discussed at the Technology Transfer Interest Group session on Tue., March 12, 10:45 – 12:15.
The session will also focus on the essentials of technology transfers, including a discussion of benchmarking, tools and tips, by Beth Haas, CAI, and John Wass, CAI.
PDA is currently working on several initiatives relating to technology transfers, which are a necessary but complex part of modern drug and biologic manufacturing. Gathering data to better understand how companies implement technology transfers and the challenges that they encounter is the first step. PDA anticipates over 200 participants in the survey. Ultimately, the goal is to incorporate findings into a potential revision of PDA Technical Report No. 65: Technology Transfer and develop additional guidance on the topic—both using the survey results and the discussion generated at the PDA conference.
Each session at the 2019 PDA Annual Meeting: Solving Manufacturing and Supply Challenges for Current and Future Medicinal Products is designed to engage attendees in discussions on improving existing processes or entirely new technologies and therapies.
"The 2019 PDA Annual Meeting offers something for everyone in the PDA community, whether they are working on technology transfers, developing innovative manufacturing strategies, or maneuvering the various regulatory hurdles to innovation," said Richard Johnson, PDA President & CEO. "I look forward to seeing the many advisory board, interest group, chapter and other volunteers who attend this meeting each year."
Richard Johnson will be available to discuss important industry trends and PDA initiatives with members of the press on Mon., March 11, 3:10 – 3:30 (room location TBD). Press passes are available to bona fide members of the press.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
SOURCE PDA
Share this article